Header Logo

Connection

WILLIAM PEACOCK to Prognosis

Back to Details
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Prognosis.
WILLIAM PEACOCK
Connection Strength
1.182
Prognosis
  1. Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost. 2019 05; 17(5):720-736.
    View in: PubMed
    Score: 0.077
  2. Practical approach on frail older patients attended for acute heart failure. Int J Cardiol. 2016 Nov 01; 222:62-71.
    View in: PubMed
    Score: 0.064
  3. Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open. 2015 Oct 28; 5(10):e009251.
    View in: PubMed
    Score: 0.061
  4. Using galectin-3 to reduce heart failure rehospitalization. Future Cardiol. 2014 Mar; 10(2):221-7.
    View in: PubMed
    Score: 0.054
  5. ST2 in emergency department patients with noncardiac dyspnea. Acad Emerg Med. 2013 Nov; 20(11):1207-10.
    View in: PubMed
    Score: 0.053
  6. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26.
    View in: PubMed
    Score: 0.036
  7. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. Ann Emerg Med. 2008 Jan; 51(1):25-34.
    View in: PubMed
    Score: 0.035
  8. Current and emerging issues with B-type natriuretic peptide. Roundtable discussion. Congest Heart Fail. 2005 Jul-Aug; 11(4):212-4.
    View in: PubMed
    Score: 0.030
  9. Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in acute coronary syndrome patients: A systematic review and meta-analysis. Kardiol Pol. 2025; 83(1):52-61.
    View in: PubMed
    Score: 0.028
  10. Predictive value of neutrophil gelatinase-associated lipocalin (NGAL) values for cardiac arrest outcomes: A systematic review and meta-analysis. Am J Emerg Med. 2024 06; 80:221-223.
    View in: PubMed
    Score: 0.027
  11. Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Kardiol Pol. 2024; 82(3):276-284.
    View in: PubMed
    Score: 0.027
  12. Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. Coron Artery Dis. 2022 08 01; 33(5):376-384.
    View in: PubMed
    Score: 0.024
  13. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study. J Card Fail. 2022 02; 28(2):226-233.
    View in: PubMed
    Score: 0.023
  14. Observation unit management of heart failure. Emerg Med Clin North Am. 2001 Feb; 19(1):209-32.
    View in: PubMed
    Score: 0.022
  15. Incidence, characteristics, determinants, and prognostic impact of recurrent syncope. Europace. 2020 12 23; 22(12):1885-1895.
    View in: PubMed
    Score: 0.022
  16. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation. 2020 10 20; 142(16):1532-1544.
    View in: PubMed
    Score: 0.021
  17. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 05; 8(5):415-422.
    View in: PubMed
    Score: 0.021
  18. The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions. Eur Heart J. 2020 04 01; 41(13):1357-1364.
    View in: PubMed
    Score: 0.021
  19. Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 2000 Mar; 35(3):213-20.
    View in: PubMed
    Score: 0.020
  20. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure. Int J Cardiol. 2020 02 01; 300:245-251.
    View in: PubMed
    Score: 0.020
  21. sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure. Acta Cardiol. 2020 Dec; 75(8):739-747.
    View in: PubMed
    Score: 0.020
  22. Prevalence of Pulmonary Embolism in Patients With Syncope. J Am Coll Cardiol. 2019 08 13; 74(6):744-754.
    View in: PubMed
    Score: 0.020
  23. The role of atrial fibrillation in the short-term outcomes of patients with acute heart failure. Clin Res Cardiol. 2019 Jun; 108(6):622-633.
    View in: PubMed
    Score: 0.019
  24. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The?ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.018
  25. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2018 01 23; 137(4):354-363.
    View in: PubMed
    Score: 0.017
  26. Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
    View in: PubMed
    Score: 0.017
  27. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017 07; 14(7):427-440.
    View in: PubMed
    Score: 0.017
  28. Is there a clinically meaningful difference in patient reported dyspnea in acute heart failure? An analysis from URGENT Dyspnea. Heart Lung. 2017 Jul - Aug; 46(4):300-307.
    View in: PubMed
    Score: 0.017
  29. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry. Chest. 2017 10; 152(4):821-832.
    View in: PubMed
    Score: 0.017
  30. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
    View in: PubMed
    Score: 0.016
  31. Association of Early Stress Testing with Outcomes for Emergency Department Evaluation of Suspected Acute Coronary Syndrome. Crit Pathw Cardiol. 2016 06; 15(2):60-8.
    View in: PubMed
    Score: 0.016
  32. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2017 Oct; 23(7):769-774.
    View in: PubMed
    Score: 0.016
  33. Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination. Thromb Res. 2016 May; 141:8-10.
    View in: PubMed
    Score: 0.015
  34. Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure. J Card Fail. 2016 Oct; 22(10):781-8.
    View in: PubMed
    Score: 0.015
  35. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail. 2015 Nov; 17(11):1114-23.
    View in: PubMed
    Score: 0.015
  36. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63.
    View in: PubMed
    Score: 0.015
  37. Emergency department patients with acute severe hypertension: a comparison of those admitted versus discharged in studying the treatment of acute hypertension registry. Crit Pathw Cardiol. 2014 Jun; 13(2):66-72.
    View in: PubMed
    Score: 0.014
  38. Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. Am Heart J. 2014 Apr; 167(4):480-488.e1.
    View in: PubMed
    Score: 0.013
  39. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013 Oct 01; 62(14):1242-1249.
    View in: PubMed
    Score: 0.013
  40. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J. 2013 Aug; 30(8):633-7.
    View in: PubMed
    Score: 0.012
  41. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study. Am J Cardiol. 2011 Mar 15; 107(6):821-6.
    View in: PubMed
    Score: 0.011
  42. Japanese-Western consensus meeting on biomarkers. Int Heart J. 2011; 52(5):253-65.
    View in: PubMed
    Score: 0.011
  43. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail. 2011 Jan; 13(1):37-42.
    View in: PubMed
    Score: 0.011
  44. Acute heart failure guidelines: moving in the right direction? Ann Emerg Med. 2011 Jan; 57(1):29-30.
    View in: PubMed
    Score: 0.011
  45. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med. 2011 Oct; 29(8):924-31.
    View in: PubMed
    Score: 0.010
  46. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010 May 11; 55(19):2062-76.
    View in: PubMed
    Score: 0.010
  47. Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011 Feb; 29(2):162-7.
    View in: PubMed
    Score: 0.010
  48. Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers. Rev Cardiovasc Med. 2010; 11 Suppl 2:S3-12.
    View in: PubMed
    Score: 0.010
  49. Emergency physician high pretest probability for acute coronary syndrome correlates with adverse cardiovascular outcomes. Acad Emerg Med. 2009 Aug; 16(8):740-8.
    View in: PubMed
    Score: 0.010
  50. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Soc Echocardiogr. 2009 Jul; 22(7):766-73.
    View in: PubMed
    Score: 0.010
  51. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008 Aug 12; 52(7):534-40.
    View in: PubMed
    Score: 0.009
  52. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):25-9.
    View in: PubMed
    Score: 0.009
  53. Inpatient monitoring and prognostic importance of B-type natriuretic peptide. Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):30-4.
    View in: PubMed
    Score: 0.009
  54. The elder patient with suspected acute coronary syndromes in the emergency department. Acad Emerg Med. 2007 Aug; 14(8):732-9.
    View in: PubMed
    Score: 0.008
  55. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 2006 Jun 15; 97(12):1707-12.
    View in: PubMed
    Score: 0.008
  56. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006 Jan 17; 47(2):312-8.
    View in: PubMed
    Score: 0.008
  57. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004 Sep-Oct; 10(5 Suppl 3):1-30.
    View in: PubMed
    Score: 0.007
  58. Troponin T in elders with suspected acute coronary syndromes. Am J Emerg Med. 2003 Jul; 21(4):293-7.
    View in: PubMed
    Score: 0.006
  59. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol. 2000 Feb 15; 85(4):421-6.
    View in: PubMed
    Score: 0.005
  60. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol. 1999 Feb; 33(2):471-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.